Cargando…
Therapy with pamidronate in children with osteogenesis imperfecta
Osteogenesis imperfecta (OI) is a genetic disease characterized by excessive bone fragility with fractures consecutive to minor trauma. Considering lack of standardization of therapy with pamidronate in children, it was our aim to present our experience over a period of 10 years regarding evolution...
Autores principales: | Marginean, Otilia, Tamasanu, Raluca Corina, Mang, Niculina, Mozos, Ioana, Brad, Giorgiana Flavia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584887/ https://www.ncbi.nlm.nih.gov/pubmed/28894358 http://dx.doi.org/10.2147/DDDT.S141075 |
Ejemplares similares
-
Short-term Efficacy of Monthly Pamidronate Infusion in Patients with Osteogenesis Imperfecta
por: Choi, Jin-Ho, et al.
Publicado: (2007) -
Pamidronate Alters the Growth Plate in the Oim Mouse Model for Osteogenesis Imperfecta
por: Evans, K. D., et al.
Publicado: (2009) -
Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta
por: Choi, Yunha, et al.
Publicado: (2022) -
Correlation between Neutrophil-to-Lymphocyte Ratio and Cerebral Edema in Children with Severe Diabetic Ketoacidosis
por: Scutca, Alexandra-Cristina, et al.
Publicado: (2023) -
Assessing the Relationship between Systemic Immune-Inflammation Index and Metabolic Syndrome in Children with Obesity
por: Nicoară, Delia-Maria, et al.
Publicado: (2023)